HUM Humana Inc. Common Stock
$382,25
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Tem 29, 2026
52 Haftlık Aralık
$163–$429
82% of range
Analist Derecelendirmesi
HOLD
33 analysts
Fiyat Hedefi
$416
+9% upside
P/E (TTM)
38.8
ROE
7.0%
Net Kâr Marjı
0.92%
Humana Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Almanya merkezli bebek maması üreticisi için Humana sayfasına bakın
Devamını oku
Almanya merkezli bebek maması üreticisi için Humana sayfasına bakın
Humana Inc., Louisville, Kentucky'de bulunan kâr amacı gütmeyen bir Amerikan sağlık sigortası şirketidir. 2014 itibarıyla Humana, ABD'de 13 milyondan fazla müşteriye sahipti, 2013 yılında 41,3 milyar ABD Doları gelir elde etti ve 51,600 çalışanı vardı. 2018 yılında, şirket Fortune 500 listesinde 56 sırada yer aldı ve Kentucky merkezli en yüksek sırada yer aldı. Ülkedeki en büyük üçüncü sağlık sigortası olmuştur.
Amerika Birleşik Devletleri Sağlık ve Sosyal Hizmetler Bakanlığı, 2009 yılında Humana'yı, AARP'ın aldatıcı olarak nitelendirdiği Medicare alıcılarına el ilanları göndermek için araştırdı. Şirketin yönetilen bakım modeli de etik gecikmeler ve sınırlamalar nedeniyle eleştirilmiştir.
Sağlık sigortası Aetna, 3 Temmuz 2015'te yaptığı açıklamada, daha küçük rakibi Humana'yı 37 milyar dolarlık nakit ve hisse senedi için kazanmayı kabul ettiğini, ancak birleşmenin rekabet karşıtı olacağına karar vermesinin ardından anlaşmadan uzaklaştığını söyledi.
Kentucky Louisville'deki Humana Binası, Michael Graves tarafından tasarlanan ve 1985 yılında tamamlanan postmodern mimarinin bir örneğidir.
Humana'nın posta siparişi tesisi olan Humana Pharmacy, Phoenixve West Chester, Ohio'da faaliyet göstermektedir. Humana'nın çağrı merkezleri, Cincinnati, Ohio ve diğer bölgelerde bulunmaktadır.
Tarihi
Avukatlar David A. Jones, Sr. ve Wendell Cherry, 1961'de bir huzurevi şirketi kurdu. 1968'de Extendicare Inc. olarak bilinen şirket, Amerika Birleşik Devletleri'ndeki en büyük bakım evi şirketi oldu. 1972'de Jones ve Cherry, hastaneleri satın almak için bakım ev zincirini sattı.
1993 yılında Humana, 77 hastaneye sahip olarak ülkenin en büyük hastane operatörü oldu. Humana yöneticileri Galen Health Care'i oluşturmak için hastane operasyonlarını sağlık sigortası operasyonlarından çıkardılar. Ertesi yıl, Galen Health Care Inc.'in 73 hastanesini Nashville merkezli Hospital Corporation of America'ya 3.4 milyar dolara sattılar.
1998'de Jones, CEO olarak ayrıldıktan bir yıl sonra United Healthcare, Humana'yı satın almak için başarısız bir girişimde bulundu. Humana, United hisse senetleri 2,9 milyar dolar değerinde düştükten sonra devralımdan çekildi. 2001'de Humana, bir Yetkinlik kurucusuydu.
2005 yılında Humana Virgin Group ile iş ortaklığına girdi ve üyelere düzenli egzersiz gibi sağlıklı davranışlar için finansal teşvikler sundu.
16 Kasım 2006'da, Hastalık Kontrol ve Önleme Merkezleri (CDC) ve Humana Inc., nüfus sağlığı yönetimine yönelik geleneksel özel sektör yaklaşımlarını genişletmek için ortaklık yaptı.
2006'da Humana, Medicare modernizasyon yasasının yürürlüğe girmesini takiben, Medicare'e uygun tüketicilere ülke çapında Medicare Advantage (MA) ve Reçeteli İlaç Planlarını (PDP) pazarlamak için bir eğitim kampanyası başlattı. Mail-order perakende eczane işletmesi sayesinde Mart 2008 sayısında Fortune Magazine, Humana'yı ABD'deki En Beğenilen 5 Sağlık Şirketinden biri olarak adlandırdı.
Humana, 2010 yılında acil bakım ve fizik tedavi merkezlerine sahip Texas merkezli Concentra'i 790 milyon dolara satın alarak etkin bir şekilde sağlık hizmetlerine geri döndürdü. Mayıs 2011'de Humana, korunan sağlık bilgilerini hastalara iletmek için mobileStorm kullanacağını açıkladı.
Mart 2015'te Humana, "2 milyar dolarlık hisse geri alım programı ve diğer şirket harcamalarını" finanse etmek üzere gelirleriyle Concentra'nın özel sermaye şirketi Welsh, Carson, Anderson & Stowe ve Select Medical Holdings Corporation'a yaklaşık 1 milyar dolar satıldığını duyurdu.
Temmuz 2015'te Aetna, Humana'yı 37 milyar dolar nakit ve hisse senedi (o sırada yaklaşık 230 $) alacağını açıkladı. Aetna ve Humana hissedarları yeni birleşik şirketin% 74'üne ve% 26'sına sahip olacaklar, ancak birleşme Ocak 2017'de federal bir hakim tarafından engellendi. 2017 yılının Şubat ayında, Aetna Inc. ve Humana Inc., hakimlerin birleşmeye karşı ikinci kez karar vermesi üzerine 34 milyar dolarlık birleşme anlaşması imzaladı.
Temmuz 2018'de, Humana, Kindred Healthcare'i satın almak için iki özel sermaye şirketine katıldı. Anlaşma, Humana'ya şirketin yaklaşık 800 milyon dolarına "Kindred at Home" adlı evde sağlık, bakım ve halk bakım işlerinde% 40'lık bir pay verdi.
Kaynakça
Dış bağlantılar
Sitesi9 Ocak 2019 tarihinde Wayback Machine sitesinde arşivlendi.
Ayrıca bakınız
Drägerwerk
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
HUM Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$382.25
Piyasa Değeri
$75.96B
P/E (TTM)
38.8
EPS (TTM)
$9.84
Gelir (TTM)
$129.66B
Temettü Verimi
0.56%
ROE
7.0%
D/E Borç/Özsermaye
0.7
52 Haftlık Aralık
$163 – $429
HUM Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$129.66B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$9.84
2016-12-31
→
2025-12-31
Serbest Nakit Akışı
$375M
2016-12-31
→
2025-12-31
Marjlar
0.92%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
HUM
Akran Ortalaması
P/E (TTM)
38.8
36.8
P/S (TTM) (F/S (TTM))
0.6
0.8
P/B (F/D)
4.3
3.4
EV / EBITDA
25.3
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
202.6
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
HUM
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
2.1%
—
Net Profit Margin (Net Kâr Marjı)
0.92%
0.85%
ROA
2.5%
2.8%
ROE
7.0%
8.2%
ROIC
7.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
HUM
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.7
—
Current Ratio (Cari Oran)
2.0
1.5
Quick Ratio (Cari Oran)
1.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
HUM
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
10.1%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
11.8%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
10.9%
—
EPS YoY (EPS YB)
-1.4%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-1.6%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
HUM
Akran Ortalaması
Payout Ratio (Temettü Ödeme Oranı)
36.2%
—
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
0.56%
Temettü Ödeme Oranı
36.2%
5 Yıllık Temettü CAGR
—
| Ex-tarihi | Miktar |
|---|---|
| 26 Haziran 2026 | $0,8850 |
| 27 Mart 2026 | $0,8850 |
| 26 Aralık 2025 | $0,8850 |
| 26 Eylül 2025 | $0,8850 |
| 27 Haziran 2025 | $0,8850 |
| 28 Mart 2025 | $0,8850 |
| 31 Aralık 2024 | $0,8850 |
| 30 Eylül 2024 | $0,8850 |
| 28 Haziran 2024 | $0,8850 |
| 27 Mart 2024 | $0,8850 |
| 28 Aralık 2023 | $0,8850 |
| 28 Eylül 2023 | $0,8850 |
| 29 Haziran 2023 | $0,8850 |
| 30 Mart 2023 | $0,8850 |
| 29 Aralık 2022 | $0,7880 |
| 29 Eylül 2022 | $0,7880 |
| 29 Haziran 2022 | $0,7880 |
| 30 Mart 2022 | $0,7880 |
| 30 Aralık 2021 | $0,7000 |
| 29 Eylül 2021 | $0,7000 |
HUM Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
33 analist
- Güçlü Al 8 24,2%
- Al 8 24,2%
- Tut 15 45,5%
- Sat 2 6,1%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
23 analist · 2026-08-19
Medyan
$415.00
Şimdi
$382.25
Düşük
$280.00
Yüksek
$513.00
Medyan hedef
$415.00
+8,6%
Ortalama hedef
$416.43
+8,9%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.42%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $7.61 | $7.29 | 0.32% |
| 31 Mart 2026 | $10.31 | $10.29 | 0.02% |
| 31 Aralık 2025 | $-3.96 | $-4.05 | 0.09% |
| 30 Eylül 2025 | $3.24 | $2.85 | 0.39% |
| 30 Haziran 2025 | $6.27 | $5.98 | 0.29% |
| 31 Mart 2025 | $11.58 | $10.17 | 1.4% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Büyüme Oranları 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Gelir Tablosu 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Bilanço 25
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Nakit Akışı 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Değerleme (TTM) 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Faaliyet Kâr Marjı % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Net Gelir | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Seyreltilmiş Hisse Başı Kâr | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Cari Oran | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Cari Oran | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $375M | $2.39B | $2.98B | $3.47B | $946M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 1.050 dosya · $33.7B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 255 (+143 önceki Ç'ye göre) | 81 (-80 önceki Ç'ye göre) | 313 (+42 önceki Ç'ye göre) | 273 (-45 önceki Ç'ye göre) | +23.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Dodge & Cox | $4.345.737.744 | 10.940.380 | 12,90% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.115.642.737 | 7.843.620 | 9,25% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.311.405.702 | 5.818.956 | 6,86% | Hisse senetleri |
| STATE STREET CORP | $2.172.441.313 | 5.457.072 | 6,45% | Hisse senetleri |
| EAGLE CAPITAL MANAGEMENT LLC | $1.528.010.749 | 3.846.762 | 4,54% | Hisse senetleri |
| Sessa Capital IM, L.P. | $1.480.732.883 | 3.727.740 | 4,40% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.181.074.714 | 2.976.242 | 3,51% | Hisse senetleri |
| Capital International Investors | $950.462.637 | 2.392.826 | 2,82% | Hisse senetleri |
| NAYA CAPITAL MANAGEMENT UK LTD | $728.407.339 | 1.833.763 | 2,16% | Hisse senetleri |
| NORGES BANK | $694.505.009 | 1.748.414 | 2,06% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $659.096.868 | 1.659.274 | 1,96% | Hisse senetleri |
| FMR LLC | $615.633.048 | 1.549.854 | 1,83% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544.502.820 | 1.370.784 | 1,62% | Hisse senetleri |
| Capital Research Global Investors | $443.462.035 | 1.116.990 | 1,32% | Hisse senetleri |
| Slate Path Capital LP | $428.969.795 | 1.079.930 | 1,27% | Hisse senetleri |
| Capital World Investors | $406.119.738 | 1.022.425 | 1,21% | Hisse senetleri |
| Newport Trust Company, LLC | $384.768.345 | 968.653 | 1,14% | Hisse senetleri |
| CITADEL ADVISORS LLC | $363.376.856 | 914.800 | 1,08% | Alım opsiyonu |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348.908.912 | 878.377 | 1,04% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $331.490.508 | 834.526 | 0,98% | Hisse senetleri |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314.921.577 | 792.814 | 0,93% | Hisse senetleri |
| CITADEL ADVISORS LLC | $310.904.094 | 782.700 | 0,92% | Satım opsiyonu |
| WELLINGTON MANAGEMENT GROUP LLP | $282.117.958 | 710.231 | 0,84% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $267.791.027 | 674.163 | 0,79% | Hisse senetleri |
| Maple Rock Capital Partners Inc. | $249.553.862 | 628.251 | 0,74% | Hisse senetleri |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245.555.446 | 618.185 | 0,73% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $232.333.978 | 584.900 | 0,69% | Alım opsiyonu |
| MARSHALL WACE, LLP | $216.873.381 | 545.978 | 0,64% | Hisse senetleri |
| CITADEL ADVISORS LLC | $178.080.082 | 448.316 | 0,53% | Hisse senetleri |
| High Ground Investment Management LLP | $177.941.848 | 447.968 | 0,53% | Hisse senetleri |
| 1832 Asset Management L.P. | $176.401.430 | 444.090 | 0,52% | Hisse senetleri |
| BCV Asset Management Inc. | $173.695.656 | 445.719 | 0,52% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $172.703.708 | 434.781 | 0,51% | Hisse senetleri |
| Holocene Advisors, LP | $165.040.541 | 415.489 | 0,49% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $147.490.964 | 371.308 | 0,44% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $140.098.700 | 352.698 | 0,42% | Hisse senetleri |
| JANE STREET GROUP, LLC | $137.080.622 | 345.100 | 0,41% | Alım opsiyonu |
| Swiss National Bank | $134.522.525 | 338.660 | 0,40% | Hisse senetleri |
| JANE STREET GROUP, LLC | $122.542.370 | 308.500 | 0,36% | Satım opsiyonu |
| STEADFAST CAPITAL MANAGEMENT LP | $122.423.204 | 308.200 | 0,36% | Hisse senetleri |
| BlackRock, Inc. | $120.890.332 | 304.341 | 0,36% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115.565.201 | 290.935 | 0,34% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $109.135.401 | 274.748 | 0,32% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $108.302.217 | 272.614 | 0,32% | Hisse senetleri |
| Legal & General Group Plc | $103.424.967 | 260.372 | 0,31% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $103.330.825 | 260.135 | 0,31% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $103.078.590 | 259.500 | 0,31% | Satım opsiyonu |
| NEUBERGER BERMAN GROUP LLC | $102.585.352 | 258.258 | 0,30% | Hisse senetleri |
| BANK OF NOVA SCOTIA | $102.313.941 | 257.575 | 0,30% | Hisse senetleri |
| RHUMBLINE ADVISERS | $102.294.748 | 257.527 | 0,30% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $101.464.685 | 255.437 | 0,30% | Hisse senetleri |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100.979.680 | 254.216 | 0,30% | Hisse senetleri |
| Gotham Asset Management, LLC | $89.318.889 | 224.860 | 0,27% | Hisse senetleri |
| Balyasny Asset Management L.P. | $87.965.958 | 221.454 | 0,26% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $85.094.587 | 214.226 | 0,25% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $83.532.585 | 210.293 | 0,25% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83.463.866 | 210.120 | 0,25% | Hisse senetleri |
| Brandywine Global Investment Management, LLC | $80.388.706 | 313.859 | 0,24% | Hisse senetleri |
| California Public Employees Retirement System | $80.274.587 | 202.091 | 0,24% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $76.135.109 | 298.300 | 0,23% | Alım opsiyonu |
| Camber Capital Management LP | $73.344.000 | 300.000 | 0,22% | Hisse senetleri |
| National Pension Service | $70.860.473 | 178.391 | 0,21% | Hisse senetleri |
| BARCLAYS PLC | $70.472.788 | 177.415 | 0,21% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $69.949.250 | 176.097 | 0,21% | Hisse senetleri |
| Walleye Trading LLC | $69.473.778 | 174.900 | 0,21% | Alım opsiyonu |
| CANADA PENSION PLAN INVESTMENT BOARD | $68.018.761 | 171.237 | 0,20% | Hisse senetleri |
| ARGA Investment Management, LP | $66.165.730 | 166.572 | 0,20% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $65.183.802 | 164.100 | 0,19% | Hisse senetleri |
| Solel Partners LP | $64.742.888 | 162.990 | 0,19% | Hisse senetleri |
| AMF Tjanstepension AB | $61.961.951 | 155.989 | 0,18% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60.794.124 | 153.049 | 0,18% | Hisse senetleri |
| Perpetual Ltd | $57.945.659 | 145.878 | 0,17% | Hisse senetleri |
| CI INVESTMENTS INC. | $57.302.560 | 144.259 | 0,17% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $56.575.256 | 142.426 | 0,17% | Hisse senetleri |
| Squarepoint Ops LLC | $56.047.742 | 141.100 | 0,17% | Satım opsiyonu |
| Aberdeen Group plc | $53.345.852 | 134.298 | 0,16% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $52.653.949 | 206.300 | 0,16% | Satım opsiyonu |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52.178.000 | 131.358 | 0,15% | Hisse senetleri |
| ING GROEP NV | $51.583.784 | 129.862 | 0,15% | Hisse senetleri |
| Squarepoint Ops LLC | $50.685.272 | 127.600 | 0,15% | Alım opsiyonu |
| Walleye Trading LLC | $49.573.056 | 124.800 | 0,15% | Satım opsiyonu |
| D. E. Shaw & Co., Inc. | $46.514.462 | 117.100 | 0,14% | Alım opsiyonu |
| BRAIDWELL LP | $45.481.690 | 114.500 | 0,14% | Hisse senetleri |
| Jain Global LLC | $43.694.200 | 110.000 | 0,13% | Satım opsiyonu |
| BANK OF MONTREAL /CAN/ | $43.207.208 | 108.774 | 0,13% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42.190.325 | 106.214 | 0,13% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42.127.167 | 106.055 | 0,13% | Hisse senetleri |
| AVIVA PLC | $41.509.093 | 104.499 | 0,12% | Hisse senetleri |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41.468.472 | 161.904 | 0,12% | Hisse senetleri |
| ROYAL BANK OF CANADA | $41.033.000 | 103.301 | 0,12% | Hisse senetleri |
| Pentwater Capital Management LP | $39.722.000 | 100.000 | 0,12% | Alım opsiyonu |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39.284.661 | 98.899 | 0,12% | Hisse senetleri |
| Point72 Asset Management, L.P. | $39.122.595 | 98.491 | 0,12% | Hisse senetleri |
| PFM Health Sciences, LP | $37.487.638 | 94.375 | 0,11% | Hisse senetleri |
| Summit Street Capital Management, LLC | $36.325.372 | 91.449 | 0,11% | Hisse senetleri |
| Columbus Hill Capital Management, L.P. | $35.501.935 | 89.376 | 0,11% | Hisse senetleri |
| Korea Investment CORP | $34.579.193 | 87.053 | 0,10% | Hisse senetleri |
| Quantinno Capital Management LP | $32.817.091 | 82.616 | 0,10% | Hisse senetleri |
| Fisher Funds Management LTD | $32.811.563 | 82.603 | 0,10% | Hisse senetleri |
| Swedbank AB | $32.034.603 | 80.647 | 0,10% | Hisse senetleri |
Şirket yöneticileri 76 içeriden öğrenenler · 46 yöneticiler · 27 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 14 Mayıs 2025 P | 30.474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 Şubat 2024 A | 110.130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 24 Şubat 2025 A | 29.676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 Aralık 2024 J | 20.165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 Şubat 2021 A | 24.342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 09 Mayıs 2014 G | 14.916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 27 Mart 2025 J | 15.702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 24 Şubat 2025 A | 16.234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 24 Şubat 2025 A | 11.566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 Şubat 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 Aralık 2022 M | 3.983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 Aralık 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 Şubat 2014 A | 105.443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 Mart 2017 J | 34.668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 24 Şubat 2025 A | 8.628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 Şubat 2025 A | 1.767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 24 Şubat 2025 A | 11.266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 24 Şubat 2025 A | 17.267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 Şubat 2025 A | 16.717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 Aralık 2024 G | 7.111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 Aralık 2024 M | 14.015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 Şubat 2024 A | 11.723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 Şubat 2023 F | 3.687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 01 Mayıs 2022 M | 4.294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 Mart 2022 J | 5.723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 Şubat 2022 F | 6.014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 Mart 2021 G | 8.168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 Aralık 2019 M | 18.092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 Aralık 2019 M | 6.339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 Şubat 2019 A | 9.774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 Şubat 2019 M | 10.791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 Aralık 2018 M | 11.136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 Aralık 2018 M | 6.476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 Mart 2017 M | 4.361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 Şubat 2014 A | 1.101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 Şubat 2014 A | 15.946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 Haziran 2013 M | 19.347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 Aralık 2012 G | 2.287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 Nisan 2012 F | 11.946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 Şubat 2012 A | 23.280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 04 Şubat 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 Mart 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 Şubat 2008 F | 13.836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 Aralık 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 Şubat 2007 M | 57.548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 06 Ocak 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Yönetim kurulu üyesi | 30 Haziran 2026 A | 19.448 | 0 | 0 | $0 |
| Frank A Damelio | Yönetim kurulu üyesi | 02 Ocak 2026 A | 20.634 | 0 | 0 | $0 |
| Karen Katz | Yönetim kurulu üyesi | 31 Aralık 2025 A | 590 | 0 | 0 | $0 |
| David T Feinberg | Yönetim kurulu üyesi | 30 Haziran 2025 A | 441 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| David A. Jones ×2 başvurular | 12 Kasım 2003 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 200 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHF · iShares Trust | 4,29% | 144.763 SH | 08 Ağustos 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,95% | 109.132 NS | 30 Nisan 2026 | N-PORT |
| SMRI · EA Series Trust | 2,54% | 58.016 NS | 30 Nisan 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,27% | 100.446 SH | 08 Ağustos 2026 | Günlük |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,26% | 2.111 NS | 30 Nisan 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 11.546 SH | 08 Ağustos 2026 | Günlük |
| SRHQ · Elevation Series Trust | 1,63% | 13.322 NS | 30 Nisan 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,60% | 32.564 SH | 08 Ağustos 2026 | Günlük |
| CVAR · ETF Opportunities Trust | 1,51% | 2.473 NS | 30 Nisan 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,20% | 225 NS | 30 Nisan 2026 | N-PORT |
| ABCS · EA Series Trust | 1,19% | 441 NS | 29 Mayıs 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,14% | 17.702 NS | 31 Mayıs 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,96% | 17.434 NS | 30 Nisan 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 52.223 NS | 30 Nisan 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771.237 SH | 08 Ağustos 2026 | Günlük |
| ITAN · EA Series Trust | 0,77% | 2.259 NS | 29 Mayıs 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,72% | 65.925 NS | 31 Mayıs 2026 | N-PORT |
| IYH · iShares Trust | 0,72% | 71.884 SH | 08 Ağustos 2026 | Günlük |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 183.164 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,70% | 360.880 SH | 08 Ağustos 2026 | Günlük |
| AUSF · Global X Funds | 0,70% | 19.401 NS | 31 Mayıs 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,63% | 211 NS | 31 Mayıs 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,59% | 30.459 NS | 30 Nisan 2026 | N-PORT |
| IXJ · iShares Trust | 0,56% | 62.953 SH | 08 Ağustos 2026 | Günlük |
| RXL · ProShares Trust | 0,53% | 1.258 NS | 31 Mayıs 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 2.755 NS | 30 Nisan 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2.601.869 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 55.439 NS | 30 Nisan 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,45% | 28.340 NS | 30 Nisan 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,43% | 3.849 NS | 29 Mayıs 2026 | N-PORT |
| IWS · iShares Trust | 0,42% | 181.221 SH | 08 Ağustos 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,41% | 2.404 NS | 30 Nisan 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,37% | 81 NS | 31 Mayıs 2026 | N-PORT |
| IMCV · iShares Trust | 0,36% | 11.394 SH | 08 Ağustos 2026 | Günlük |
| QARP · DBX ETF Trust | 0,36% | 887 NS | 29 Mayıs 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,35% | 10.520.000 | 08 Ağustos 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,35% | 90.057 SH | 08 Ağustos 2026 | Günlük |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,34% | 4.484 NS | 31 Mayıs 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,34% | 1.004 NS | 31 Mayıs 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,32% | 265.500 NS | 31 Mayıs 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 7.839 SH | 08 Ağustos 2026 | Günlük |
| IWR · iShares Trust | 0,32% | 489.015 SH | 08 Ağustos 2026 | Günlük |
| IMCB · iShares Trust | 0,30% | 13.840 SH | 08 Ağustos 2026 | Günlük |
| FNDB · SCHWAB STRATEGIC TRUST | 0,29% | 12.439 NS | 31 Mayıs 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,29% | 2.779 NS | 30 Nisan 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,28% | 1.250 NS | 31 Mayıs 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 320.000 | 08 Ağustos 2026 | Günlük |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,27% | 299 NS | 31 Mayıs 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,26% | 12.272 NS | 30 Nisan 2026 | N-PORT |
| VLUE · iShares Trust | 0,24% | 62.558 SH | 08 Ağustos 2026 | Günlük |